| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study S Yusuf, S Hawken, S Ôunpuu, T Dans, A Avezum, F Lanas, M McQueen, ... The lancet 364 (9438), 937-952, 2004 | 17190 | 2004 |
| Apixaban in patients with atrial fibrillation SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ... New England Journal of Medicine 364 (9), 806-817, 2011 | 3320 | 2011 |
| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 2379 | 2017 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2275 | 2019 |
| Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries CK Chow, KK Teo, S Rangarajan, S Islam, R Gupta, A Avezum, ... Jama 310 (9), 959-968, 2013 | 2184 | 2013 |
| Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study MJ O'Donnell, SL Chin, S Rangarajan, D Xavier, L Liu, H Zhang, ... The lancet 388 (10046), 761-775, 2016 | 2168 | 2016 |
| Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort … S Yusuf, P Joseph, S Rangarajan, S Islam, A Mente, P Hystad, M Brauer, ... The Lancet 395 (10226), 795-808, 2020 | 1380 | 2020 |
| Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study M Dehghan, A Mente, X Zhang, S Swaminathan, W Li, V Mohan, R Iqbal, ... The Lancet 390 (10107), 2050-2062, 2017 | 1190 | 2017 |
| Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective … S Yusuf, S Islam, CK Chow, S Rangarajan, G Dagenais, R Diaz, R Gupta, ... The Lancet 378 (9798), 1231-1243, 2011 | 1081 | 2011 |
| Cardiovascular risk and events in 17 low-, middle-, and high-income countries S Yusuf, S Rangarajan, K Teo, S Islam, W Li, L Liu, J Bo, Q Lou, F Lu, ... New England Journal of Medicine 371 (9), 818-827, 2014 | 1067 | 2014 |
| Urinary sodium and potassium excretion, mortality, and cardiovascular events M O'Donnell, A Mente, S Rangarajan, MJ McQueen, X Wang, L Liu, H Yan, ... New England Journal of Medicine 371 (7), 612-623, 2014 | 1033 | 2014 |
| Association of urinary sodium and potassium excretion with blood pressure A Mente, MJ O'Donnell, S Rangarajan, MJ McQueen, P Poirier, ... New england journal of medicine 371 (7), 601-611, 2014 | 969 | 2014 |
| A microgrid energy management system based on the rolling horizon strategy R Palma-Behnke, C Benavides, F Lanas, B Severino, L Reyes, J Llanos, ... IEEE Transactions on smart grid 4 (2), 996-1006, 2013 | 953 | 2013 |
| Dronedarone in high-risk permanent atrial fibrillation SJ Connolly, AJ Camm, JL Halperin, C Joyner, M Alings, J Amerena, ... New England Journal of Medicine 365 (24), 2268-2276, 2011 | 813 | 2011 |
| Investigators IS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study S Yusuf, S Hawken, S Ounpuu, T Dans, A Avezum, F Lanas, M McQueen, ... Lancet 364 (9438), 937-52, 2004 | 803 | 2004 |
| Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial SH Hohnloser, Z Hijazi, L Thomas, JH Alexander, J Amerena, M Hanna, ... European heart journal 33 (22), 2821-2830, 2012 | 723 | 2012 |
| Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study F Lanas, A Avezum, LE Bautista, R Diaz, M Luna, S Islam, S Yusuf Circulation 115 (9), 1067-1074, 2007 | 687 | 2007 |
| Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study GR Dagenais, DP Leong, S Rangarajan, F Lanas, P Lopez-Jaramillo, ... The Lancet 395 (10226), 785-794, 2020 | 658 | 2020 |
| Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study V Miller, A Mente, M Dehghan, S Rangarajan, X Zhang, S Swaminathan, ... The Lancet 390 (10107), 2037-2049, 2017 | 626 | 2017 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 535 | 2019 |
